Methodology · Updated September 29, 2026

How does HRT Picks score providers?

HRT Picks gives each reviewed provider a public-information score out of 10. We assess five things a reader can check before deciding: the product, price, care process, dispensing pharmacy and purchase terms. Each earns 0, 1 or 2 points. The total comes directly from those five assessments, with no adjustment for affiliate payment.

Public-information score, not a clinical quality or treatment-effectiveness rating. Each of five checks earns 0 for unestablished information, 1 for partial information or 2 for clear disclosure. A missing fact is not proof of poor care. Affiliate payments do not affect points. Read the treatment scope and dated source notes with the total. A provider may earn points for clear terms even when those terms do not suit you. A low score can reflect missing or conflicting public information; it does not prove poor care. The separate, retained A–F grades are historical disclosure assessments.

What earns points?

The same five criteria apply to every reviewed provider. Two points mean the relevant information is clear and sufficiently specific in the recorded sources; one means partial disclosure or a material unresolved detail; zero means the relevant information was not established. The reason beside each criterion explains the decision.

Treatment details · 0–2 points
Two points for a clearly identified treatment and route; one for partial or conflicting product information.
Payment clarity · 0–2 points
Two points when the selected plan's first payment, renewal, term and required fees are clear; one when only part of the bill is established.
Care process · 0–2 points
Two points for named clinical responsibility, eligibility and follow-up information; one when the process is only partly described.
Pharmacy disclosure · 0–2 points
Two points for an identified dispensing pharmacy for the reviewed treatment; one for a general pharmacy network or local-fill choice.
Cancellation and refunds · 0–2 points
Two points for clear, relevant cancellation timing and refund rules; one for partial rules or unresolved conflicts.

Total = product + price + care + pharmacy + terms. No additional weighting, reputation bonus or promotional adjustment applies.

What changed on September 29, 2026?

We replaced the earlier weighted editorial ratings. Some retained ratings could not be reproduced from their evidence-only calculations, and that calibration was not a defensible basis for comparing providers. The replacement measures the narrower question the sources can support: how complete and clear is the public information?

All current totals below use the replacement method. This is a correction to the scoring system, not a claim that a provider's care improved or deteriorated. Source-check dates remain visible; updating this page does not make an older source check current.

How was each provider's score calculated?

These 17 assessments cover every published provider review, including separately labeled ED programs, retained research providers and paused offers. An assessment does not establish current program availability. Open the review for that status and the exact treatment options.

Hers Menopause: 8.0/10 public-information score

Scope: Hers menopause HRT; weight-loss pricing, policies and platform-wide review ratings are not substituted for this service.. Evidence assessment dated 2026-09-29.

Treatment details: 2/2
The page identifies estradiol pills or patches, progesterone pills and estradiol vaginal cream as possible components of the clinician-selected menopause plan.
Payment clarity: 1/2
The official insurance guide still publishes oral $79/month and patch $134/month starting rates on 12-month plans. The selected upfront charge, complete kit price and billing schedule remain unverified.
Care process: 2/2
The landing names Dr. Shepherd, describes provider evaluation and continuing check-ins, and the terms identify the affiliated You Health medical groups. These disclosures do not identify each patient's eventual prescriber.
Pharmacy disclosure: 1/2
The terms identify a pharmacy network and allow outside-pharmacy fulfillment. They do not map the individual menopause prescription to a specific dispensing pharmacy before intake.
Cancellation and refunds: 2/2
The general prescription-subscription terms describe cancellation two days before renewal, end-of-period effect, account and support methods, and no refund for partially used periods. Weight-loss-specific exceptions are kept separate.
Read the Hers Menopause review →
Sesame Care: 8.0/10 public-information score

Scope: The dedicated menopause subscription, not unrelated Sesame marketplace visits.. Evidence assessment dated 2026-09-29.

Treatment details: 2/2
The menopause program names estradiol, estrogen/progestin, progesterone and prasterone options, alongside non-hormonal treatments. Prescribing remains conditional on the selected clinician's assessment.
Payment clarity: 1/2
The page separates the subscription from pharmacy medication charges and describes basic labs with state-specific payment exceptions. A complete first and repeat treatment bill was not established from the public page.
Care process: 2/2
Named credentialed clinicians, patient-selected video care, medical-history review, as-needed labs and ongoing messaging are described for this menopause program.
Pharmacy disclosure: 1/2
The prescription is sent to the patient's preferred local pharmacy. That establishes pharmacy choice but does not identify a single dispenser or its licensing for an individual prescription.
Cancellation and refunds: 2/2
The menopause-specific policy states the three-hour initial-visit cancellation deadline, no first-month refund after that visit, and cancellation before the next billing cycle to prevent renewal.
Read the Sesame Care review →
Winona: 8.0/10 public-information score

Scope: Menopause HRT, using the estradiol patch and published care policies as the assessed treatment path.. Evidence assessment dated 2026-09-29.

Treatment details: 2/2
The patch page identifies estradiol, its transdermal route, available strengths and FDA-approved status. This finding does not extend FDA approval to Winona's compounded creams.
Payment clarity: 1/2
The patch starts at $149 per month with care and shipping included. The selected dose, billing interval and any additional progesterone need confirmation before the complete bill is known.
Care process: 2/2
Medical evaluation, physician messaging and dose adjustments are described. The terms name Dr. Michael Green as chief medical officer and president of the affiliated medical practice.
Pharmacy disclosure: 1/2
The terms allow a prescription to be filled through the patient's selected pharmacy. The checked pages do not identify the specific dispensing pharmacy for the advertised patch.
Cancellation and refunds: 2/2
The help policy explains a 24-hour order-cancellation window, no refund after pharmacy preparation, and separate steps for ending future subscription refills.
Read the Winona review →
Wisp: 8.0/10 public-information score

Scope: Menopause consultation and locally filled HRT prescriptions.. Evidence assessment dated 2026-09-29.

Treatment details: 2/2
The consultation page identifies estradiol patch, gel and oral options separately from oral progesterone or progestin options. The treatment is selected after medical assessment.
Payment clarity: 1/2
The current page advertises care from $33 per month and explicitly excludes pharmacy medication costs. It does not establish the complete medication bill or the selected upfront billing interval.
Care process: 2/2
The page names Dr. Shannon Chatham, DO, describes medical-history and eligibility review, and provides continuing care-team access with treatment adjustments.
Pharmacy disclosure: 1/2
The menopause prescription goes to a local pharmacy, where the patient pays separately. No single dispensing pharmacy is assigned by the public consultation page.
Cancellation and refunds: 2/2
Published terms require cancellation at least 48 hours before renewal, provide account and support cancellation methods, and explain final-sale and discretionary refund exceptions.
Read the Wisp review →
DudeMeds: 7.0/10 public-information score

Scope: Standard testosterone cypionate TRT, using the product page, TRT consent and sales terms together.. Evidence assessment dated 2026-09-29.

Treatment details: 2/2
The product page identifies testosterone cypionate and the injection route. This assessment concerns that injection; enclomiphene marketed elsewhere on the site is not testosterone replacement.
Payment clarity: 1/2
The $77 headline is public, but the selector and sales terms do not consistently establish required laboratory charges. The terms also retain an initial three-month medication payment obligation.
Care process: 2/2
The TRT consent names LocumTele as the medical group, makes treatment conditional on history and labs, and describes follow-up testing. Naming the group does not verify an individual clinician's license.
Pharmacy disclosure: 1/2
The terms permit a patient-chosen pharmacy, with unchanged DudeMeds fees and medication charges paid separately. They do not identify the default TRT dispensing pharmacy.
Cancellation and refunds: 1/2
Cancellation instructions and non-refundable dispensing are published, but cancel-anytime wording sits alongside a continuing obligation to pay for the first three months. Confirm the selected plan's remaining balance.
Read the DudeMeds review →
Hone Health: 7.0/10 public-information score

Scope: Men's TRT through Plus and women's HRT through Premium; membership and medication costs remain separate.. Evidence assessment dated 2026-09-29.

Treatment details: 2/2
Separate men's and women's plan pages name the hormones, routes and compounded formulations. Testosterone cypionate is quoted per vial; enclomiphene is distinguished from testosterone replacement.
Payment clarity: 1/2
The pages publish $135 men's Plus and $155 women's Premium memberships, initial testing and medication estimates. Dose-dependent medication charges prevent a universal complete treatment total.
Care process: 1/2
Baseline testing, physician video evaluation, TRT confirmatory testing and follow-up labs are described. These checked plan pages do not identify the individual treating clinician or responsible medical entity.
Pharmacy disclosure: 1/2
Hone explicitly allows patients to choose a local pharmacy and explains separate pharmacy billing. The exact dispenser still depends on medication, availability and the patient's prescription.
Cancellation and refunds: 2/2
The policy distinguishes membership cancellation from prescription cancellation, explains processing limits for medication refunds and makes clear that stopping one billing stream does not automatically stop the other.
Read the Hone Health review →
Midi Health: 7.0/10 public-information score

Scope: Menopause clinical HRT care; the separately approved supplement shop does not establish clinical affiliate approval.. Evidence assessment dated 2026-09-29.

Treatment details: 2/2
The HRT page identifies estrogen treatment forms and progesterone or progestin where indicated, and describes FDA-approved bioidentical hormones separately from unrelated products.
Payment clarity: 1/2
The $250 initial and $150 returning self-pay visits are published, alongside insurance limits. Medication, testing and insurance cost sharing still prevent a complete treatment total before individual assessment.
Care process: 2/2
The terms name the clinical medical groups. The HRT page describes symptom and history assessment, testing where needed, follow-ups and clinician-directed dose changes.
Pharmacy disclosure: 1/2
The terms name Precision Compounding Pharmacy and permit pharmacy choice. They do not establish that this pharmacy dispenses every HRT product or identify the dispenser for an individual prescription.
Cancellation and refunds: 1/2
General terms explain product and subscription refunds and cancellation. The checked pages do not fully settle the clinical visit's cancellation fee and refund rules for every appointment type.
Read the Midi Health review →
PeterMD: 7.0/10 public-information score

Scope: Injectable testosterone replacement, with product-specific prices kept separate from enclomiphene and longevity products.. Evidence assessment dated 2026-09-29.

Treatment details: 2/2
The men's TRT page identifies injectable testosterone cypionate. This does not establish that PeterMD's separately marketed oral hormone or longevity products are the same treatment.
Payment clarity: 1/2
Monthly and prepaid plan tiers are public, including $139 month to month. Inconsistent total text and an incomplete public accounting of required labs and checkout fees prevent full credit.
Care process: 1/2
The page describes baseline bloodwork, licensed-provider eligibility review and a 90-day check-in. It does not identify the assigned clinician or responsible medical group for this TRT path.
Pharmacy disclosure: 1/2
The terms name Absolute Pharmacy and Partell Pharmacy with contact details and allow pharmacy choice. They do not map the selected testosterone product to its actual dispensing pharmacy.
Cancellation and refunds: 2/2
The refund and auto-bill policy states a 48-hour renewal-cancellation deadline, final sales once medication is received and a 24-hour deadline for reporting defective or damaged deliveries.
Read the PeterMD review →
Enhanced: 6.0/10 public-information score

Scope: Injectable TRT and separate oral enclomiphene. Evidence assessment dated 2026-09-29.

Treatment details: 2/2
The reviewed routes distinguish injectable testosterone from oral enclomiphene. Prescription eligibility is a clinician decision; the two drugs are not interchangeable.
Payment clarity: 1/2
The initial assessment offer is separated from medication. The recurring prescription charge, repeat-lab charges and complete payment schedule are not established before assessment.
Care process: 2/2
The program describes baseline and follow-up lab monitoring and clinical eligibility review. Terms identify OpenLoop or Beluga as possible clinical providers; the assigned clinician remains individual-specific.
Pharmacy disclosure: 0/2
Terms refer to independent licensed pharmacies but do not identify the dispenser for the reviewed testosterone or enclomiphene prescription.
Cancellation and refunds: 1/2
The guarantee expressly excludes testosterone and limits eligible medication refunds. The reviewed material does not settle the selected plan's ordinary renewal cancellation deadline.
Read the Enhanced review →
Fella Health: 6.0/10 public-information score

Scope: Standalone oral enclomiphene; not an injectable TRT quote. Evidence assessment dated 2026-09-29.

Treatment details: 2/2
The reviewed hormone offer names oral enclomiphene. Separate or historical testosterone references do not establish a current TRT product.
Payment clarity: 2/2
The standalone page distinguishes the monthly payment from six-month prepayment and describes medication, labs and coaching as included. The weight-loss add-on is a separate offer.
Care process: 1/2
Testing, medical review and coaching are described. The membership agreement's obesity focus limits what it establishes about the standalone hormone-care team and follow-up.
Pharmacy disclosure: 0/2
The checked hormone-program and agreement pages do not establish which named pharmacy dispenses the reviewed enclomiphene prescription.
Cancellation and refunds: 1/2
Renewal and written termination rules exist, but the agreement is framed around obesity care. The guarantee excludes additional treatments, leaving hormone-specific refund scope unresolved.
Read the Fella Health review →
Gala Health: 6.0/10 public-information score

Scope: Gala's /lp/hrt1 monthly HRT offer. The alternate /lp/hrt offer has different product prices and 12-week billing terms.. Evidence assessment dated 2026-09-29.

Treatment details: 2/2
The landing identifies estradiol pills or patches, oral progesterone and vaginal estradiol. Its product claims do not independently verify the exact manufacturer or final dispensed formulation.
Payment clarity: 2/2
The current HRT offer states the same $69 monthly plan price from the start, including the online visit, prescription treatment and standard shipping, with no separate membership fee.
Care process: 1/2
The landing describes clinical assessment, state-dependent video visits and symptom-guided dose adjustments. The checked HRT and consent pages do not name the treating clinicians or their medical group.
Pharmacy disclosure: 0/2
The checked landing and consent refer to licensed partner pharmacies without naming the HRT dispenser. This is an unresolved identity disclosure, not evidence that a pharmacy is unlicensed.
Cancellation and refunds: 1/2
The linked policy gives a 72-hour cancellation cutoff and medical-disqualification refund exception, but still uses weight-loss-specific service wording. Confirm its application to the selected HRT plan.
Read the Gala Health review →
Maximus: 6.0/10 public-information score

Scope: The injectable testosterone protocol and its commitment-plan terms, not other Maximus treatment lines.. Evidence assessment dated 2026-09-29.

Treatment details: 2/2
The injectable page identifies testosterone, its injection route and compounded-medication limitations. It describes fertility suppression rather than treating the protocol as interchangeable with enclomiphene.
Payment clarity: 1/2
The page publishes one-, three- and six-month prices and an introductory discount. Required blood tests and applicable video consultations are excluded in the terms, leaving the complete first bill unresolved.
Care process: 1/2
Required labs, physician evaluation and ongoing adjustments are described. Named medical advisers appear on the company page, but their role does not identify the responsible treating clinician or medical group.
Pharmacy disclosure: 0/2
The checked protocol and company pages describe licensed US compounding pharmacies but do not name the actual dispensing pharmacy for the injectable product.
Cancellation and refunds: 2/2
The commitment-plan terms explain automatic renewal, cancellation before renewal, continuing payment obligations after mid-term cancellation and the documented health-related exception. These are restrictive but disclosed terms.
Read the Maximus review →
Ageless: 5.0/10 public-information score

Scope: Try Ageless testosterone catalog; partner offer paused. Evidence assessment dated 2026-09-29.

Treatment details: 1/2
Testosterone options are listed, but route text conflicts and a controlled-substance exclusion in the terms leave current treatment availability unresolved.
Payment clarity: 1/2
Dose-dependent headline prices and a consultation fee are disclosed. Conflicting product-page amounts prevent a dependable complete treatment quote.
Care process: 1/2
Wasef Health and Michael Wasef, MD are identified. Clinical review is described, but the conflicting prescribing policy leaves the actual testosterone pathway unresolved.
Pharmacy disclosure: 1/2
Pharmacy Hub is named for the general service. The actual testosterone prescription and dispensing pathway remain unconfirmed; this is not an independent pharmacy audit.
Cancellation and refunds: 1/2
Clinical fees, renewal restrictions and prepaid cancellation deductions are published. Their application to the conflicting testosterone listings needs clarification.
Read the Ageless review →
MangoRx: 5.0/10 public-information score

Scope: The testosterone-support program described in the current FAQs; other MangoRx product lines are not scored as TRT evidence.. Evidence assessment dated 2026-09-29.

Treatment details: 1/2
The current FAQ describes oral Prime testosterone support, but the linked TRT product page did not expose the full treatment menu or formulation details in this check.
Payment clarity: 1/2
The February company release quotes $99/month including labs, while the current FAQ lists $75/$100 tests separately. Current medication pricing and the full first and repeat bill remain unresolved.
Care process: 1/2
The FAQ specifies recent baseline bloodwork and follow-up within 60 days. It describes licensed providers but does not name the responsible TRT clinician or medical group.
Pharmacy disclosure: 1/2
The FAQ permits pharmacy choice. It also describes an unnamed Texas compounding partner, so product-specific dispensing identity remains unresolved.
Cancellation and refunds: 1/2
The FAQ explains account cancellation and final sales after fulfillment. The separate refund page is partly framed around GLP-1 appointments, leaving TRT-specific appointment and renewal cutoffs unclear.
Read the MangoRx review →
Taurus Meds: 5.0/10 public-information score

Scope: Testosterone assessment and subsequent treatment quote. Evidence assessment dated 2026-09-29.

Treatment details: 1/2
The entry offer clearly describes testosterone assessment. It does not establish the medication, formulation and route a shopper would receive.
Payment clarity: 1/2
The test-and-consultation charge is explicit. Medication is paid later, and the related price landing and membership terms leave the full recurring bill unresolved.
Care process: 1/2
Labs, a video consultation and clinical eligibility are described. The assigned clinician and product-specific long-term monitoring schedule are not established.
Pharmacy disclosure: 1/2
The reviewed legal disclosures identify a pharmacy network, not the pharmacy assigned to this testosterone prescription. Ask for the actual dispenser before payment.
Cancellation and refunds: 1/2
Subscription and non-refund rules are published, alongside an ineligibility-refund statement. Their application to the selected assessment and prescription requires confirmation.
Read the Taurus Meds review →
TMates: 5.0/10 public-information score

Scope: Testosterone cypionate care. Evidence assessment dated 2026-09-29.

Treatment details: 2/2
The reviewed program identifies injectable testosterone cypionate. The exact dispensed product's manufacturer or compounding status still requires confirmation.
Payment clarity: 1/2
Plan totals and included medication/labs are published. The next charge, any separate clinical fee and the selected prescription's complete terms still need confirmation.
Care process: 1/2
Intake, clinician review and follow-up testing are described. The checked clinician page does not identify the assigned practitioner, and baseline-lab language is inconsistent.
Pharmacy disclosure: 0/2
The public program does not identify the dispensing pharmacy for testosterone. A general reference to registered US pharmacies is not a named dispenser.
Cancellation and refunds: 1/2
Terms describe refund restrictions after medical review or pharmacy submission and payment-plan obligations. A clear TRT-specific renewal cutoff is not established.
Read the TMates review →
FeelGood Meds: 4.0/10 public-information score

Scope: Compounded liquid ED offer; not HRT or TRT. Evidence assessment dated 2026-09-29.

Treatment details: 1/2
The offer identifies a compounded liquid ED product. Confirm the complete formula for the selected QUAD prescription; the format is not testosterone replacement.
Payment clarity: 1/2
A multi-month promotion is visible. The final quantity, ongoing charge and exact subscription choice still require a written confirmation.
Care process: 1/2
The terms distinguish the platform from clinical decision-makers and require prescription approval. Product-specific follow-up and the assigned clinician are not established.
Pharmacy disclosure: 0/2
The checked ED offer and terms do not identify the pharmacy that will dispense the selected compound.
Cancellation and refunds: 1/2
The policy gives a 72-hour billing cutoff, while the offer says cancellation is possible before pharmacy submission. Refund categories are explained, but the controlling deadline needs confirmation.
Read the FeelGood Meds review →

What do the retained Transparency Grades mean?

The A–F grades are separate, dated legacy assessments of pre-intake disclosure. They were not recalculated from the new score and are not clinical quality grades. A new review may have a public-information score without a legacy grade. Consult the review's original verification date before relying on one.

The legacy checks covered pricing before intake, named clinicians and credentials, cancellation policy, corporate disclosure and third-party review access. An unanswered BBB F rating or a corroborated billing-surprise pattern caps the grade at D regardless of disclosure. Accountability is part of transparency: a company that publishes every price and then stops answering complaints has not told you the thing you most needed to know. Those historical rules do not add or subtract points from today's public-information score.

See the provider reviews and their dated records →

Does payment affect coverage or scoring?

Payment never changes criterion points or the total. Approval does determine access to our shopping catalog, which therefore does not cover the whole market. Paused offers do not receive an active partner exit. Separately disclosed promotional placements use the existing eligibility rules; an eligible score is not a clinical endorsement.

Read the promotional placement rules →

FAQ

Frequently asked questions

What does the HRT Picks provider score measure?

The public-information score measures how clearly a provider documents its product, price, care process, dispensing pharmacy and purchase terms. Each criterion earns 0, 1 or 2 points, for a total out of 10. It is not a clinical quality rating, patient outcome measure or recommendation to receive treatment.

Can I reproduce the score?

Yes. Add the five criterion points in the provider's assessment below. Every criterion includes its reason and the source records used. A missing or contradictory disclosure can reduce the score; it does not establish that the care is poor or the provider is unsafe.

Does an affiliate relationship improve the score?

No. The scoring record does not use approval status, commission or payout. Our shopping catalog is limited to approved programs, so it is not the whole market. Reviews of retained research providers and paused offers remain separately labeled. Promotional placements have separate eligibility and disclosure rules.